vs
AVADEL PHARMACEUTICALS PLC（AVDL）与RE/MAX Holdings, Inc.（RMAX）财务数据对比。点击上方公司名可切换其他公司
AVADEL PHARMACEUTICALS PLC的季度营收约是RE/MAX Holdings, Inc.的1.1倍（$77.5M vs $71.1M），RE/MAX Holdings, Inc.净利率更高（2.0% vs 0.0%，领先2.0%），AVADEL PHARMACEUTICALS PLC同比增速更快（54.9% vs -1.8%），RE/MAX Holdings, Inc.自由现金流更多（$33.5M vs $22.2M），过去两年AVADEL PHARMACEUTICALS PLC的营收复合增速更高（99.6% vs -4.7%）
Avadel Pharmaceuticals是爱尔兰的专科制药企业，专注于睡眠障碍治疗药物的研发，产品覆盖医院及基层医疗场景，总部位于爱尔兰都柏林，在美国密苏里州圣路易斯、法国里昂均设有业务运营点。
RE/MAX是全球知名的房地产特许经营机构，业务遍布全球一百多个国家和地区，旗下拥有数千家门店，总计超过十万名房产经纪人，在国际房产中介领域拥有极高的品牌知名度与市场影响力。
AVDL vs RMAX — 直观对比
营收规模更大
AVDL
是对方的1.1倍
$71.1M
营收增速更快
AVDL
高出56.7%
-1.8%
净利率更高
RMAX
高出2.0%
0.0%
自由现金流更多
RMAX
多$11.3M
$22.2M
两年增速更快
AVDL
近两年复合增速
-4.7%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $77.5M | $71.1M |
| 净利润 | $20.0K | $1.4M |
| 毛利率 | — | — |
| 营业利润率 | 2.5% | 13.1% |
| 净利率 | 0.0% | 2.0% |
| 营收同比 | 54.9% | -1.8% |
| 净利润同比 | 100.8% | -75.2% |
| 每股收益（稀释后） | $0.00 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVDLRMAX
| Q4 25 | — | $71.1M | ||
| Q3 25 | $77.5M | $73.2M | ||
| Q2 25 | $68.1M | $72.8M | ||
| Q1 25 | $52.5M | $74.5M | ||
| Q4 24 | $50.4M | $72.5M | ||
| Q3 24 | $50.0M | $78.5M | ||
| Q2 24 | $41.5M | $78.5M | ||
| Q1 24 | $27.2M | $78.3M |
净利润AVDLRMAX
| Q4 25 | — | $1.4M | ||
| Q3 25 | $20.0K | $4.0M | ||
| Q2 25 | $9.7M | $4.7M | ||
| Q1 25 | $-4.9M | $-2.0M | ||
| Q4 24 | $-5.0M | $5.8M | ||
| Q3 24 | $-2.6M | $966.0K | ||
| Q2 24 | $-13.8M | $3.7M | ||
| Q1 24 | $-27.3M | $-3.4M |
毛利率AVDLRMAX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 90.7% | — | ||
| Q1 25 | 89.4% | — | ||
| Q4 24 | 90.5% | — | ||
| Q3 24 | 87.7% | — | ||
| Q2 24 | 93.3% | — | ||
| Q1 24 | 94.4% | — |
营业利润率AVDLRMAX
| Q4 25 | — | 13.1% | ||
| Q3 25 | 2.5% | 25.0% | ||
| Q2 25 | 13.0% | 19.3% | ||
| Q1 25 | -5.7% | 7.2% | ||
| Q4 24 | -6.5% | 5.9% | ||
| Q3 24 | -0.7% | 19.4% | ||
| Q2 24 | -30.7% | 20.6% | ||
| Q1 24 | -95.8% | 5.8% |
净利率AVDLRMAX
| Q4 25 | — | 2.0% | ||
| Q3 25 | 0.0% | 5.4% | ||
| Q2 25 | 14.2% | 6.4% | ||
| Q1 25 | -9.4% | -2.6% | ||
| Q4 24 | -10.0% | 8.0% | ||
| Q3 24 | -5.2% | 1.2% | ||
| Q2 24 | -33.3% | 4.7% | ||
| Q1 24 | -100.6% | -4.3% |
每股收益（稀释后）AVDLRMAX
| Q4 25 | — | — | ||
| Q3 25 | $0.00 | — | ||
| Q2 25 | $0.10 | — | ||
| Q1 25 | $-0.05 | — | ||
| Q4 24 | $-0.04 | — | ||
| Q3 24 | $-0.03 | — | ||
| Q2 24 | $-0.14 | — | ||
| Q1 24 | $-0.30 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $91.6M | $118.7M |
| 总债务越低越好 | — | $432.2M |
| 股东权益账面价值 | $98.2M | $452.4M |
| 总资产 | $199.4M | $582.5M |
| 负债/权益比越低杠杆越低 | — | 0.96× |
8季度趋势，按日历期对齐
现金及短期投资AVDLRMAX
| Q4 25 | — | $118.7M | ||
| Q3 25 | $91.6M | $107.5M | ||
| Q2 25 | $81.5M | $94.3M | ||
| Q1 25 | $66.5M | $89.1M | ||
| Q4 24 | $73.8M | $96.6M | ||
| Q3 24 | $65.8M | $83.8M | ||
| Q2 24 | $71.4M | $66.1M | ||
| Q1 24 | $88.8M | $82.1M |
总债务AVDLRMAX
| Q4 25 | — | $432.2M | ||
| Q3 25 | — | $433.3M | ||
| Q2 25 | — | $434.4M | ||
| Q1 25 | — | $435.3M | ||
| Q4 24 | — | $436.2M | ||
| Q3 24 | — | $437.2M | ||
| Q2 24 | — | $438.1M | ||
| Q1 24 | — | $439.0M |
股东权益AVDLRMAX
| Q4 25 | — | $452.4M | ||
| Q3 25 | $98.2M | $448.1M | ||
| Q2 25 | $90.7M | $442.4M | ||
| Q1 25 | $74.1M | $433.5M | ||
| Q4 24 | $73.8M | $429.5M | ||
| Q3 24 | $74.7M | $423.1M | ||
| Q2 24 | $70.3M | $418.4M | ||
| Q1 24 | $78.4M | $412.0M |
总资产AVDLRMAX
| Q4 25 | — | $582.5M | ||
| Q3 25 | $199.4M | $582.2M | ||
| Q2 25 | $187.2M | $574.8M | ||
| Q1 25 | $167.9M | $571.4M | ||
| Q4 24 | $164.2M | $581.6M | ||
| Q3 24 | $158.3M | $578.6M | ||
| Q2 24 | $157.5M | $571.4M | ||
| Q1 24 | $167.9M | $566.7M |
负债/权益比AVDLRMAX
| Q4 25 | — | 0.96× | ||
| Q3 25 | — | 0.97× | ||
| Q2 25 | — | 0.98× | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | 1.02× | ||
| Q3 24 | — | 1.03× | ||
| Q2 24 | — | 1.05× | ||
| Q1 24 | — | 1.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $22.2M | $40.9M |
| 自由现金流经营现金流 - 资本支出 | $22.2M | $33.5M |
| 自由现金流率自由现金流/营收 | 28.7% | 47.1% |
| 资本支出强度资本支出/营收 | 0.0% | 10.4% |
| 现金转化率经营现金流/净利润 | 1110.25× | 28.39× |
| 过去12个月自由现金流最近4个季度 | — | $56.8M |
8季度趋势，按日历期对齐
经营现金流AVDLRMAX
| Q4 25 | — | $40.9M | ||
| Q3 25 | $22.2M | $17.7M | ||
| Q2 25 | $12.7M | $4.6M | ||
| Q1 25 | $-8.2M | $5.7M | ||
| Q4 24 | $7.9M | $59.7M | ||
| Q3 24 | $-6.9M | $17.6M | ||
| Q2 24 | $-18.2M | $15.9M | ||
| Q1 24 | $-29.7M | $9.4M |
自由现金流AVDLRMAX
| Q4 25 | — | $33.5M | ||
| Q3 25 | $22.2M | $16.4M | ||
| Q2 25 | — | $2.9M | ||
| Q1 25 | — | $4.0M | ||
| Q4 24 | — | $53.0M | ||
| Q3 24 | — | $16.3M | ||
| Q2 24 | — | $14.0M | ||
| Q1 24 | — | $6.8M |
自由现金流率AVDLRMAX
| Q4 25 | — | 47.1% | ||
| Q3 25 | 28.7% | 22.4% | ||
| Q2 25 | — | 4.0% | ||
| Q1 25 | — | 5.3% | ||
| Q4 24 | — | 73.2% | ||
| Q3 24 | — | 20.8% | ||
| Q2 24 | — | 17.8% | ||
| Q1 24 | — | 8.6% |
资本支出强度AVDLRMAX
| Q4 25 | — | 10.4% | ||
| Q3 25 | 0.0% | 1.8% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | 2.3% | ||
| Q4 24 | — | 9.1% | ||
| Q3 24 | 0.0% | 1.7% | ||
| Q2 24 | — | 2.4% | ||
| Q1 24 | — | 3.3% |
现金转化率AVDLRMAX
| Q4 25 | — | 28.39× | ||
| Q3 25 | 1110.25× | 4.45× | ||
| Q2 25 | 1.31× | 0.97× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 10.28× | ||
| Q3 24 | — | 18.22× | ||
| Q2 24 | — | 4.29× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVDL
暂无分部数据
RMAX
| Franchising Segment | $50.1M | 70% |
| Broker Fees | $13.9M | 20% |
| Annual Dues | $7.4M | 10% |
